Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR9.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR2.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR1.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR4.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR3.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR8.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR7.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR6.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR22.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR23.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR13.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR24.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR17.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR11.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR19.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR15.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR27.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR12.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR14.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR25.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR16.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR26.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR10.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR18.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR20.htm
EX-10.1 - EXHIBIT 10.1 - HEALTH DISCOVERY CORPex10-1.htm
EX-32.1 - EXHIBIT 32.1 - HEALTH DISCOVERY CORPex32-1.htm
EX-10.2 - EXHIBIT 10.2 - HEALTH DISCOVERY CORPex10-2.htm
EX-31.1 - EXHIBIT 31.1 - HEALTH DISCOVERY CORPex31-1.htm
10-Q - FORM 10-Q - HEALTH DISCOVERY CORPt74989_10q.htm
XML - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPR21.htm
v2.4.0.6
Statements of Cash Flows (unaudited) (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash Flows From Operating Activities    
Net Income / (Loss) $ 694,635 $ (1,669,644)
Adjustments to Reconcile Net Income (Loss) to Net Cash Used for Operating Activities:    
Stock-based Compensation 100,000  
Services Exchanged for Options 86,859 61,018
Gain on Payables Restructuring   (483,658)
Realized Gain on Sale of Available for Sale Securities Measured in Accordance with the Fair Value Option (Note G) (337,841)  
Unrealized Gain on Investment in Available forSale Securities Measured in Accordance with the Fair Value Option (Note G) (1,502,580)  
(Increase) Decrease in Deferred Charges (202,850) 5,232
Depreciation and Amortization 204,774 204,182
(Increase) Decrease in Accounts Receivable (170) 334,710
Decrease in Recoverable Development Costs   96,248
Decrease in Deferred Revenue (278,813) (85,526)
Decrease in Prepaid Expenses and Other Assets 45,350 10,180
Decrease in Accounts Payable - Trade (215,788) (125,891)
Decrease in Accrued Liabilities (15,250) (99,902)
Net Cash Used for Operating Activities (1,421,674) (1,753,051)
Cash Flows From Investing Activities:    
Proceeds from Sale of Available for Sale Securities (Note G) 922,711  
Purchase of Equipment (3,879) (3,798)
Net Cash Provided by (Used for) Investing Activities 918,832 (3,798)
Cash Flows From Financing Activities:    
Dividends Paid   (16,501)
Net Cash Used for Financing Activities   (16,501)
Net Decrease in Cash (502,842) (1,773,350)
Cash, at Beginning of Period 890,326 3,295,630
Cash, at End of Period $ 387,484 $ 1,522,280